Boyu Sun

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Efficacy and safety of immune checkpoint inhibitors in patients with high microsatellite instability/mismatch repair-deficient advanced cholangiocarcinoma: A propensity score-matched study.

Efficacy and safety of immune checkpoint inhibitors in patients with high microsatellite instability/mismatch repair-deficient advanced cholangiocarcinoma: A propensity score-matched study.

Journal: JHEP reports : innovation in hepatology

Published: December 11, 2025

Effectiveness and conversion outcomes of immune checkpoint inhibitors combined with lenvatinib and GEMOX chemotherapy as first-line treatment for advanced gallbladder cancer: A multicenter study.

Effectiveness and conversion outcomes of immune checkpoint inhibitors combined with lenvatinib and GEMOX chemotherapy as first-line treatment for advanced gallbladder cancer: A multicenter study.

Journal: Chinese medical journal

Published: December 02, 2025

Real-world outcomes of first-line immunotherapy and subsequent systemic therapies in pleural mesothelioma: a multicenter study in China.

Real-world outcomes of first-line immunotherapy and subsequent systemic therapies in pleural mesothelioma: a multicenter study in China.

Journal: Translational lung cancer research

Published: November 25, 2025

Peripheral PD-1⁺ T cell signatures predict immunotherapy response and survival in hepatobiliary cancers.

Peripheral PD-1⁺ T cell signatures predict immunotherapy response and survival in hepatobiliary cancers.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: October 26, 2025

Local-regional therapy plus ICIs, chemotherapy, and lenvatinib versus ICIs plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter study.

Local-regional therapy plus ICIs, chemotherapy, and lenvatinib versus ICIs plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter study.

Journal: Cancer immunology, immunotherapy : CII

Published: August 28, 2025

AARS1 promotes tumor progression and immune evasion via ATF6 lactylation-mediated tryptophan metabolism in hepatocellular carcinoma.

AARS1 promotes tumor progression and immune evasion via ATF6 lactylation-mediated tryptophan metabolism in hepatocellular carcinoma.

Journal: Cell metabolism

Published: August 14, 2025

Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancer.

Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: August 07, 2025

Lenvatinib enhances the response of biliary tract cancer to anti-HER2 therapy.

Lenvatinib enhances the response of biliary tract cancer to anti-HER2 therapy.

Journal: Signal transduction and targeted therapy

Published: July 31, 2025

Local-regional therapy combined with immune checkpoint inhibitors and lenvatinib versus immune checkpoint inhibitors plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter cohort study.

Local-regional therapy combined with immune checkpoint inhibitors and lenvatinib versus immune checkpoint inhibitors plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter cohort study.

Journal: Cancer immunology, immunotherapy : CII

Published: May 27, 2025

Local therapy overcomes primary resistance to target-immunotherapy combination in unresectable hepatocellular carcinoma.

Local therapy overcomes primary resistance to target-immunotherapy combination in unresectable hepatocellular carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: May 20, 2025

Global research landscape and trends of immunotherapy in biliary tract cancers.

Global research landscape and trends of immunotherapy in biliary tract cancers.

Journal: Chinese medical journal

Published: May 08, 2025

Spatiotemporal landscape of intrahepatic cholangiocarcinoma liver metastasis at the single-cell level.

Spatiotemporal landscape of intrahepatic cholangiocarcinoma liver metastasis at the single-cell level.

Journal: Hepatology (Baltimore, Md.)

Published: April 29, 2025

Showing 1-12 of 21

Last Updated: 09/26/2026